Evidence map›Paper›PMID 41672722›Full record

ArticleRMD open2026

Salvage therapy with JAK inhibitors in refractory Takayasu arteritis: a multicentre experience.

Arsène Mekinian, Sarah Meneses, Lucie Biard, Lorenzo Dagna, Pavel Novikov, Carlo Salvarani, Olivier Espitia, José Hernández-Rodríguez, Karim Sacre, Bertrand Lioger and 13 more

Abstract readLetter
In one paragraph

Article in RMD open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Arsène MekinianSorbonne Université, AP-HP, Hôpital Saint Antoine, service de médecine interne et Inflammation-Immunopathology-Biotherapy Department (DMU i3), France and French Armenian research center, Paris, France arsene.mekinian@aphp.fr.ORCID http://orcid.org/0000-0003-2849-3049
Sarah MenesesUniversité de Paris, AP-HP, Hôpital Saint Louis, Service de Biostatistique et Information Médicale (DMU PRISME), INSERM U1153 Team ECSTRRA, Paris, France.
Lucie BiardUniversité de Paris, AP-HP, Hôpital Saint Louis, Service de Biostatistique et Information Médicale (DMU PRISME), INSERM U1153 Team ECSTRRA, Paris, France.
Lorenzo DagnaUnit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.ORCID http://orcid.org/0000-0002-7428-315X
Pavel NovikovTareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University, Moscow, Russia.
Carlo SalvaraniDivision of Rheumatology, Azienda USL-IRCCS of Reggio Emilia, University of Modena and Reggio Emilia, Reggio Emilia, Italy.ORCID http://orcid.org/0000-0001-5426-5133
Olivier EspitiaCHU Nantes, Department of internal and vascular medicine, Nantes Universite, Nantes, France.ORCID http://orcid.org/0000-0003-0821-9990
José Hernández-RodríguezVasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Karim SacreDépartement de Médecine Interne, Hôpital Bichat, Université de Paris, Assistance Publique Hôpitaux de Paris, INSERM U1149, Paris, France.ORCID http://orcid.org/0000-0002-6544-234X
Bertrand LiogerService de médecine interne, CHU de Blois, Blois, France.
Virginie DufrostUniversity of Lorraine, Inserm UMR_S 1116, CHRU de Nancy, Vascular Medicine Division and national reference Center for Rare Vascular and Systemic Autoimmune Diseases, Nancy, France.
Alexandra Audemard-VergerDepartment of Internal Medicine and Clinical Immunology, CHRU Tours, University of Tours, Tours, France.
Alessandro TomelleriUnit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.ORCID http://orcid.org/0000-0002-5440-2078
Masataka KuwanaDepartment of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0001-8352-6136
Vahan MukuchyanDepartment of Internal Medicine and Rheumatology, Nairi Hospital, Erevan, Armenia.
Azeddine DellalService de rhumatologie, Hôpital Montfermeil, GHI Le Raincy Montfermeil, Montfermeil, France.
Francesco MuratoreDivision of Rheumatology, Azienda USL-IRCCS of Reggio Emilia, University of Modena and Reggio Emilia, Reggio Emilia, Italy.ORCID http://orcid.org/0000-0003-0362-2668
Corrado CampochiaroUnit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.ORCID http://orcid.org/0000-0001-6806-3794
Sergey MoiseevTareev Clinic of Internal Diseases, Sechenov First Moscow State Medical University, Moscow, Russia.
Patrice CacoubDepartment of Internal Medicine and Clinical Immunology France, Centre national de référence maladies Autoimmunes Systémiques rares, Centre national de référence maladies Autoinflammatoires et Amylose, and Inflammation-Immunopathology-Biotherapy Department (DMU i3), Sorbonne Université, AP-HP, Hôpital Pitié Salpetrière, Paris, France.
Olivier FainSorbonne Université, AP-HP, Hôpital Saint Antoine, service de médecine interne et Inflammation-Immunopathology-Biotherapy Department (DMU i3), France and French Armenian research center, Paris, France.
David SaadounDepartment of Internal Medicine and Clinical Immunology France, Centre national de référence maladies Autoimmunes Systémiques rares, Centre national de référence maladies Autoinflammatoires et Amylose, and Inflammation-Immunopathology-Biotherapy Department (DMU i3), Sorbonne Université, AP-HP, Hôpital Pitié Salpetrière, Paris, France.
French Takayasu network

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biological TherapyGiant Cell ArteritisSystemic vasculitis

Identifiers

PMID41672722
PMCPMC12911730

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.